← FDA Drug Approvals (Drugs@FDA)

TOBRAMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUOXIN AUROVITAS · Approved 2021-01-22

Drug application

FDA Application #

ANDA210871

Application type

Abbreviated New Drug Application (Generic)

Brand name

TOBRAMYCIN

Generic name

TOBRAMYCIN

Active ingredients

TOBRAMYCIN

Dosage form

SOLUTION

Route

INHALATION

Marketing status

Discontinued

Sponsor

LUOXIN AUROVITAS

Manufacturer

Aurobindo Pharma Limited

First approval

2021-01-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown